In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 0.01 a new company low.

Within Major Pharmaceutical Preparations industry 626 other companies have achieved higher Quick Ratio than Sangui Biotech International Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 378 to 5697.

Explain Quick Ratio?
How much Cash & cash equivalents SGBI�s has?
What are SGBI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SGBI Quick Ratio	(Mar 31 2023) Q3	(Dec 31 2022) Q2	(Sep 30 2022) Q1	(Jun 30 2022) Q4	(Mar 31 2022) Q3
Y / Y Current Liabilities Change	5.2 %	0.7 %	-5.88 %	-2 %	2.5 %
Y / Y Cash & cash equivalent Change	-89.67 %	12.61 %	-50.05 %	2.35 %	481.9 %
Quick Ratio MRQ	0.01	0.01	0.01	0.03	0.07
SGBI's Total Ranking	# 5697	# 378	# 5665	# 4630	# 4962
Seq. Current Liabilities Change	3.63 %	8.72 %	-2.6 %	-4.14 %	-0.8 %
Seq. Cash & cash equivalent Change	-25.02 %	39.05 %	-78.01 %	-54.94 %	717.42 %

Quick Ratio third quarter 2023 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 627
Healthcare Sector	# 1234
Overall Market	# 5697

Quick Ratio Statistics
High	Average	Low
0.54	0.11	0.01
(Dec 31 2013)		(Mar 31 2023)

Financial Statements
Sangui Biotech International Inc's Current Liabilities	$ 1 Millions	Visit SGBI's Balance sheet
Sangui Biotech International Inc's Cash & cash equivalent	$ 0 Millions	Visit SGBI's Balance sheet
Source of SGBI's Sales		Visit SGBI's Sales by Geography

Cumulative Sangui Biotech International Inc's Quick Ratio

SGBI's Quick Ratio for the trailling 12 Months

SGBI Quick Ratio	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months	(Jun 30 2022) 12 Months	(Mar 31 2022) 12 Months
Y / Y Current Liabilities TTM Growth	-0.47 %	-1.17 %	-0.23 %	3.34 %	8.59 %
Y / Y Cash & cash equivalent TTM Growth	-55.1 %	80.9 %	77.65 %	67.85 %	109.38 %
Quick Ratio TTM	0.01	0.03	0.03	0.03	0.03
Total Ranking TTM	# 4662	# 4671	# 2534	# 4982	# 4666
Seq. Current Liabilities TTM Growth	1.33 %	0.18 %	-1.47 %	-0.49 %	0.62 %
Seq. Cash & cash equivalent TTM Growth	-53.14 %	0.92 %	-5.6 %	0.59 %	88.78 %

Quick ratio ranking by company, industry and sector >> Back to SGBI Financial Strength Comparisons >> Go to Compare SGBI Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2023 to $1.03 millions, cumulative Quick Ratio decreased to 0.01 below the Sangui Biotech International Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 598 other companies have achieved higher Quick Ratio than Sangui Biotech International Inc. While Quick Ratio overall ranking has improved so far to 4662, from total ranking during the twelve months ending second quarter 2022 at 4671.

Explain Quick Ratio?
How much Cash & cash equivalents SGBI�s has?
What are SGBI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 599
Healthcare Sector	# 1193
Within the Market	# 4662

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.22	0.07	0.01
(Dec 31 2016)		(Mar 31 2023)

Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry	Quick Ratio	Mar 31 2023 MRQ Cash & cash equivalent	Mar 31 2023 MRQ Current Liabilities
Ocean Biomedical Inc	0.02	$ 0.306 Millions	$ 17.178 Millions
Regen Biopharma Inc	0.02	$ 0.088 Millions	$ 5.336 Millions
Biostax Corp	0.01	$ 0.048 Millions	$ 3.576 Millions
Serina Therapeutics Inc	0.01	$ 0.280 Millions	$ 21.448 Millions
Intellipharmaceutics International Inc	0.01	$ 0.070 Millions	$ 5.623 Millions
Axim Biotechnologies Inc	0.01	$ 0.059 Millions	$ 4.863 Millions
Oncotelic Therapeutics Inc	0.01	$ 0.190 Millions	$ 17.597 Millions
Skinvisible Inc	0.01	$ 0.029 Millions	$ 2.726 Millions
Viveon Health Acquisition Corp	0.01	$ 0.078 Millions	$ 7.841 Millions
Evofem Biosciences Inc	0.01	$ 0.639 Millions	$ 79.808 Millions
Sangui Biotech International Inc	0.01	$ 0.007 Millions	$ 1.027 Millions
Theralink Technologies Inc	0.00	$ 0.228 Millions	$ 53.422 Millions
Provectus Biopharmaceuticals Inc	0.00	$ 0.034 Millions	$ 8.660 Millions
Rapid Therapeutic Science Laboratories Inc	0.00	$ 0.018 Millions	$ 4.463 Millions
Novaccess Global Inc	0.00	$ 0.022 Millions	$ 5.830 Millions
Kaya Holdings Inc	0.00	$ 0.030 Millions	$ 9.690 Millions
Adhera Therapeutics Inc	0.00	$ 0.069 Millions	$ 23.197 Millions
Q Biomed inc	0.00	$ 0.023 Millions	$ 9.906 Millions
REGENEREX PHARMA, INC.	0.00	$ 0.001 Millions	$ 0.519 Millions

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.